Walleye Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.14M Sell
3,900
-12,800
-77% -$4.21M ﹤0.01% 1949
2025
Q4
$5.85M Sell
16,700
-8,400
-33% -$2.84M 0.02% 1025
2025
Q3
$8.11M Sell
25,100
-400
-2% -$124K 0.03% 638
2025
Q2
$9.92M Buy
25,500
+15,000
+143% +$6.03M 0.04% 503
2025
Q1
$4.57M Sell
10,500
-12,800
-55% -$5.14M 0.02% 845
2024
Q4
$8.6M Sell
23,300
-4,500
-16% -$1.88M 0.02% 728
2024
Q3
$14.5M Buy
27,800
+9,200
+49% +$4.91M 0.03% 497
2024
Q2
$10.1M Sell
18,600
-2,300
-11% -$1.22M 0.02% 750
2024
Q1
$10.8M Buy
20,900
+15,800
+310% +$7.86M 0.02% 785
2023
Q4
$2.4M Sell
5,100
-9,700
-66% -$4.49M 0.01% 1650
2023
Q3
$6.44M Buy
14,800
+10,300
+229% +$4.67M 0.02% 865
2023
Q2
$2M Buy
4,500
+2,700
+150% +$1.25M 0.01% 1329
2023
Q1
$828K Buy
+1,800
New +$857K 0.01% 1305
2020
Q1
Sell
-6,700
Closed -$2.02M 1138
2019
Q4
$2.02M Sell
6,700
-8,200
-55% -$2.26M 0.13% 193
2019
Q3
$3.58M Buy
+14,900
New +$4.08M 0.21% 95
2019
Q2
Sell
-100
Closed -$29K 1812
2019
Q1
$29K Buy
+100
New +$28.9K ﹤0.01% 1300

Other funds holding ELV

Walleye Capital's ELV Position: Q1 2026 in Review

Walleye Capital reduced its Elevance Health (ELV) stake by 97% in Q1 2026, selling an estimated $34.9M and leaving 3,024 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #2192.

Walleye Capital first reported a position in ELV in Q3 2018 and has held it in 17 quarters since. The position peaked at $38.3M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Walleye Capital held 3,024 shares of Elevance Health worth $885K as of Q1 2026.
  • Walleye Capital sold 106,159 Elevance Health shares in Q1 2026, an estimated $34.9M.
  • Elevance Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2192 holding.
  • Walleye Capital first reported a position in Elevance Health in Q3 2018 and has held it in 17 quarters since.
  • Walleye Capital's Elevance Health position peaked at $38.3M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.